Загрузка...
Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors
Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that activate the immune system, aiming at enhancing antitumor immunity. Their clinical efficacy is well-documented, but the side effects associated with their use are still under investigation. These drugs cause several immune-related ad...
Сохранить в:
| Опубликовано в: : | Int J Mol Sci |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7247001/ https://ncbi.nlm.nih.gov/pubmed/32403289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21093389 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|